Winrho

Product Specs	Description
Manufacturer Name	Cangene Corp
Indications	Children with chronic or acute ITP, adults with chronic ITP, or children and adults with ITP secondary to HIV infection, and suppression of Rh Isoimmunization.
Contraindications	Patients who have had known anaphylactic or severe systemic reaction to the administration of human immune globulin products. IgA deficient patients with antibodies to IgA and a history of hypersensitivity. Patients with autoimmune hemolytic anemia, with pre-existing hemolysis or at high risk for hemolysis. Infants for the suppression of Rho(D) isoimmunization.
Viral Safety Process	Solvent/detergent, nanofiltration, anion exchange column chromatography
Route of Administration	IV or IM depending on indication
Clearance of Rh-positive Red Blood Cells	A 1500 IU dose will suppress the immunizing potential of approximately 17 mL of RhoD positive RBCs
Product Half-Life	24 days IV, 30 days IM
Latex Content	No
Thimerosal Content	No, there are no preservatives, including mercury-based or thimerosal-based preservatives in the formulation.
Storage Requirements/Shelf Life	Refrigerate at 2°C to 8°C (36°F to 46°F). Do not use past expiration date listed on label. Protect from light. Do not freeze.
Supply Method	Vial
Available Sizes	1500 IU (300 mcg) 2500 IU (500 mcg) 5000 IU (1000 mcg) 15000 IU (3000 mcg)

About